stockrow
Friday 6 November 2026
Export XBIT’s income statement to Excel — free account
XBiotech Inc.
XBIT Healthcare Biotechnology
XBiotech Inc.’s revenue for fiscal 2022 (year ended December 2022) was $4.0 million.
- EPS
- −266.7%
- Free cash flow
- +25.3%
Quarter to June 2026, against a year earlier
1.88
0.01
+0.53%
Follow XBIT
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
41.48 | 15.88 | 38.60 | 32.75 | |
Current Ratio |
41.78 | 16.01 | 39.03 | 33.15 | |
Net Debt/EBITDA |
26.22 | 4.27 | 19.43 | 18.74 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.71 | 0.85 | 1.63 | 0.67 | |
Capex/Depreciation |
(0.26) | (0.09) | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.14) | (0.75) | (0.29) | (0.15) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.14) | (0.75) | (0.29) | (0.15) | |
Cash per Share |
4.83 | 4.12 | 3.79 | 3.59 | |
Shareholders Equity per Share |
5.48 | 4.60 | 4.43 | 4.21 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.48 | 4.60 | 4.43 | 4.21 | |
Free Cash Flow |
(4.37) | (22.99) | (8.97) | (4.51) | |
Working Capital |
145.39 | 119.02 | 114.05 | 107.81 | |
Capital Expenditures |
(0.11) | (0.03) | — | — | |
Net Current Asset Value |
143.61 | 117.22 | 112.23 | 105.97 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Receivables |
0.70 | 0.61 | 0.47 | 0.46 | |
Average Payables |
1.27 | 1.88 | 0.98 | 1.27 | |
Average Assets |
191.14 | 174.59 | 160.85 | 156.17 | |
Average Common Equity |
179.60 | 161.31 | 154.87 | 150.76 |
Columns are period end dates